U.S. Treasury Moves to Block American Money From Building China’s AI, Supercomputing, Biotech and Hypersonic Capabilities
The U.S. Treasury Department has proposed a major expansion of restrictions on American investment in sensitive technologies in China and other countries of concern, targeting artificial intelligence, supercomputing, biotechnology, semiconductors, quantum technologies and hypersonic systems. The proposal matters because Washington is no longer treating capital as separate from technology transfer. American money can provide far more than financing: it can help foreign companies scale faster, recruit talent, improve governance, enter international markets and develop capabilities with military or intelligence value. For China, which has made AI, advanced computing and emerging technology central to its national strategy, access to U.S. capital can accelerate the very capabilities Washington is trying to prevent from strengthening a strategic competitor.
The new rule would implement the Comprehensive Outbound Investment National Security Act passed by Congress in 2025, expanding a program that originally focused on certain U.S. investments involving China, Hong Kong and Macau in semiconductors, quantum computing and artificial intelligence. The revised framework reaches additional countries and additional technologies, including biotechnology, supercomputing and hypersonic systems. Investments above $50,000 could face reporting requirements or outright restrictions depending on the technology involved, while many ordinary portfolio investments such as purchases of publicly traded stocks would remain outside the program. Treasury has opened the proposal to public comment before issuing a final rule, meaning the exact compliance obligations may still change, but the direction of U.S. policy is already clear: American capital should not be allowed to help build sensitive capabilities that could later be used against American interests.
China is the most important part of that problem. Beijing has spent years directing enormous resources toward technologies with both commercial and military applications. Artificial intelligence can improve civilian productivity, but it can also support surveillance, intelligence analysis, autonomous weapons, cyber operations and military decision-making.
Supercomputing can accelerate scientific research while also supporting weapons modeling and advanced military systems. Biotechnology can produce medical breakthroughs while creating national-security concerns involving genetic information and dual-use research. Hypersonic technology is directly relevant to military systems designed to travel at more than five times the speed of sound and potentially challenge existing missile defenses. When U.S. investors help Chinese companies working in these fields scale their businesses, the value they provide may ultimately extend beyond commercial returns.
That is why outbound-investment controls are becoming as important as export controls. Washington has spent years tightening restrictions on advanced chips, semiconductor equipment and other technologies headed to China. But blocking physical technology while allowing American capital to accelerate Chinese companies in adjacent strategic sectors creates an obvious gap. A foreign firm does not need to receive a U.S. chip or proprietary design directly to benefit from American participation. Investment can bring management expertise, professional networks, international credibility and access to future funding. Those advantages can shorten development cycles and reduce the cost of competing with American companies.
The Treasury program is designed to address that gap. The department’s existing Outbound Investment Security Program already restricts or requires notification for certain transactions involving Chinese entities active in AI, semiconductors and quantum technologies. That system is no longer theoretical. In July 2026, Treasury imposed its first civil penalty under the program, fining U.S.-based Amidi, LLC $200,000 after a controlled foreign subsidiary invested approximately $92,500 in a Chinese company developing artificial intelligence, robotics and embodied intelligence without submitting the required notification. That enforcement action showed that Washington is willing to treat outbound-investment controls as real compliance obligations rather than symbolic policy statements.
For American investors, this creates a new due-diligence reality. Venture-capital firms, private-equity funds, multinational corporations and other investors cannot assume that a Chinese startup should be evaluated only through the traditional lens of financial return. They increasingly need to understand what the company actually develops, whether its technology falls within a sensitive sector, who controls the company and whether the investment could contribute to military, surveillance or intelligence capabilities. Compliance systems will need to examine beneficial ownership, subsidiaries, technical products and the destination of capital much more closely than in ordinary foreign investment screening.
The reason is simple: capital can become strategic infrastructure. A $5 million or $50 million investment into an advanced Chinese AI company does not merely appear on a balance sheet. It may pay for engineers, data centers, chips, laboratories, acquisitions and overseas expansion. It may also signal to other investors that the company has passed the scrutiny of a respected American fund, helping it raise even more money. If the company later develops technology useful to the Chinese military or security state, the original U.S. investment may have helped build the foundation for that capability.
China’s broader industrial system makes this concern especially serious. The boundary between civilian and military technology is often difficult to maintain in fields such as artificial intelligence, aerospace, quantum computing and advanced materials. Technologies developed for logistics, robotics or autonomous navigation can also be relevant to drones and weapons systems. Large-scale computing infrastructure built for commercial AI models may also support military research or intelligence applications. For Washington, the challenge is therefore not limited to identifying companies that openly manufacture weapons. The more difficult task is determining when apparently commercial investment contributes to a technology ecosystem that can strengthen Chinese state power.
The proposed rule reflects that reality by broadening the scope beyond the original three sectors. Biotechnology and hypersonic systems are particularly significant additions. China has invested heavily in biotechnology and genomics, while American policymakers have increasingly treated biological data and advanced life-science capabilities as strategic assets. Hypersonic systems are even more directly connected to military competition. Preventing U.S. capital from accelerating such technologies is a logical extension of the same principle behind semiconductor export controls: American resources should not make it easier for a strategic competitor to overcome technological disadvantages.
The policy also addresses a deeper structural weakness in globalization. For decades, American investors were encouraged to view access to China primarily as a commercial opportunity. The assumption was that capital could flow toward the highest returns while security concerns were handled separately through export controls, sanctions and traditional defense policy. That division has become harder to maintain because the most commercially valuable emerging technologies are increasingly the same technologies that shape military power, intelligence capabilities and national resilience.
Artificial intelligence is the clearest example. An AI company can build consumer products and military-relevant systems using many of the same underlying models, chips and engineering talent. A startup developing autonomous navigation can serve warehouses today and defense platforms tomorrow. A supercomputing company can support scientific research while also accelerating weapons simulation. The same technical foundation can move between commercial and strategic uses with very little warning.
That creates a direct risk for the United States. American capital could strengthen competitors that later challenge American companies commercially, support Chinese military modernization or reduce the effectiveness of U.S. technology controls. The long-term cost can be far greater than the short-term investment return.
The new rule does not ban all investment in China, nor does it attempt to isolate ordinary commercial activity. Many publicly traded securities and smaller transactions remain outside the proposed restrictions, and the system focuses on defined categories of technology judged to present national-security risks. That distinction is important because the policy is designed around strategic capability rather than ordinary trade.
For U.S. companies, the practical message is that investment compliance is becoming part of national-security compliance. Firms that already maintain export-control and sanctions programs may need to integrate outbound-investment screening into those systems. Investors will need technical expertise capable of determining whether a company’s products fall within AI, supercomputing, biotechnology or other restricted categories. Legal teams will need to understand ownership structures and whether an apparently independent firm is connected to a covered entity or country.
The broader strategic message is even more important. The United States has spent decades creating many of the technologies that now define global power. American universities, companies and investors helped build the modern semiconductor industry, cloud computing, biotechnology and artificial intelligence. Protecting that advantage requires more than preventing source code or advanced chips from leaving the country. It also requires making sure American money does not accelerate competing ecosystems in areas that directly affect U.S. national security.
China has already demonstrated that it intends to compete aggressively in these technologies. Its government has made advanced manufacturing, AI, biotechnology and military modernization major national priorities. That does not mean every Chinese technology company serves the military, but it does mean American investors need to understand the strategic environment in which their capital operates.
Treasury’s proposed rule signals that Washington is increasingly willing to treat investment as part of that competition. The United States is not simply deciding what technologies China should be allowed to buy. It is also deciding whether American investors should help finance the development of sensitive technologies inside China in the first place. For American businesses, that means a deal that looks profitable on paper may carry a much larger strategic cost. For national security, the principle is straightforward: U.S. capital should not become the fuel that helps a strategic competitor close critical technology gaps that American taxpayers, companies and workers spent decades and billions of dollars creating.
